Global Allergy Immunotherapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Allergy Immunotherapy market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.

The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Allergy Immunotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

ALK-Abello

Stallergenes Greer

Merck

Allergy Therapeutics

HAL

Holister Stier

Leti

Product Type Insights

Global markets are presented by Allergy Immunotherapy type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Allergy Immunotherapy are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Allergy Immunotherapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Allergy Immunotherapy market.

Allergic Rhinitis

Allergic Asthma

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Allergy Immunotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Allergy Immunotherapy industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapy

1.1 Allergy Immunotherapy Product Introduction

1.2 Market by Type

1.2.1 Global Allergy Immunotherapy Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Subcutaneous Immunotherapy

1.2.3 Sublingual Immunotherapy

1.3 Market by Application

1.3.1 Global Allergy Immunotherapy Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Allergic Rhinitis

1.3.3 Allergic Asthma

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Allergy Immunotherapy Market Size Estimates and Forecasts

2.1.1 Global Allergy Immunotherapy Revenue 2017-2028

2.1.2 Global Allergy Immunotherapy Sales 2017-2028

2.2 Allergy Immunotherapy Market Size by Region: 2022 Versus 2028

2.3 Allergy Immunotherapy Sales by Region (2017-2028)

2.3.1 Global Allergy Immunotherapy Sales by Region: 2017-2022

2.3.2 Global Allergy Immunotherapy Sales Forecast by Region (2023-2028)

2.3.3 Global Allergy Immunotherapy Sales Market Share by Region (2017-2028)

2.4 Allergy Immunotherapy Market Estimates and Projections by Region (2023-2028)

2.4.1 Global Allergy Immunotherapy Revenue by Region: 2017-2022

2.4.2 Global Allergy Immunotherapy Revenue Forecast by Region (2023-2028)

2.4.3 Global Allergy Immunotherapy Revenue Market Share by Region (2017-2028)

3.1 Global Top Allergy Immunotherapy Manufacturers by Sales

3.1.1 Global Allergy Immunotherapy Sales by Manufacturer (2017-2022)

3.1.2 Global Allergy Immunotherapy Sales Market Share by Manufacturer (2017-2022)

3.2 Global Top Allergy Immunotherapy Manufacturers by Revenue

3.2.1 Global Allergy Immunotherapy Revenue by Manufacturer (2017-2022)

3.2.2 Global Allergy Immunotherapy Revenue Share by Manufacturer (2017-2022)

3.3 Global Allergy Immunotherapy Price by Manufacturer (2017-2022)

3.4 Competitive Landscape

3.4.1 Key Allergy Immunotherapy Manufacturers Covered: Ranking by Revenue

3.4.2 Global Allergy Immunotherapy Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.4.3 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Allergy Immunotherapy Manufacturing Base Distribution, Product Type

3.5.1 Allergy Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Allergy Immunotherapy Product Type

3.5.3 Date of International Manufacturers Enter into Allergy Immunotherapy Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 ALK-Abello

4.1.1 ALK-Abello Corporation Information

4.1.2 ALK-Abello Description, Business Overview

4.1.3 ALK-Abello Allergy Immunotherapy Products Offered

4.1.4 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.1.5 ALK-Abello Allergy Immunotherapy Sales by Product in 2021

4.1.6 ALK-Abello Allergy Immunotherapy Sales by Application in 2021

4.1.7 ALK-Abello Allergy Immunotherapy Sales by Geographic Area in 2021

4.1.8 ALK-Abello Recent Developments

4.2 Stallergenes Greer

4.2.1 Stallergenes Greer Corporation Information

4.2.2 Stallergenes Greer Description, Business Overview

4.2.3 Stallergenes Greer Allergy Immunotherapy Products Offered

4.2.4 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.2.5 Stallergenes Greer Allergy Immunotherapy Sales by Product in 2021

4.2.6 Stallergenes Greer Allergy Immunotherapy Sales by Application in 2021

4.2.7 Stallergenes Greer Allergy Immunotherapy Sales by Geographic Area in 2021

4.2.8 Stallergenes Greer Recent Developments

4.3 Merck

4.3.1 Merck Corporation Information

4.3.2 Merck Description, Business Overview

4.3.3 Merck Allergy Immunotherapy Products Offered

4.3.4 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.3.5 Merck Allergy Immunotherapy Sales by Product in 2021

4.3.6 Merck Allergy Immunotherapy Sales by Application in 2021

4.3.7 Merck Allergy Immunotherapy Sales by Geographic Area in 2021

4.3.8 Merck Recent Developments

4.4 Allergy Therapeutics

4.4.1 Allergy Therapeutics Corporation Information

4.4.2 Allergy Therapeutics Description, Business Overview

4.4.3 Allergy Therapeutics Allergy Immunotherapy Products Offered

4.4.4 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.4.5 Allergy Therapeutics Allergy Immunotherapy Sales by Product in 2021

4.4.6 Allergy Therapeutics Allergy Immunotherapy Sales by Application in 2021

4.4.7 Allergy Therapeutics Allergy Immunotherapy Sales by Geographic Area in 2021

4.4.8 Allergy Therapeutics Recent Developments

4.5 HAL

4.5.1 HAL Corporation Information

4.5.2 HAL Description, Business Overview

4.5.3 HAL Allergy Immunotherapy Products Offered

4.5.4 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.5.5 HAL Allergy Immunotherapy Sales by Product in 2021

4.5.6 HAL Allergy Immunotherapy Sales by Application in 2021

4.5.7 HAL Allergy Immunotherapy Sales by Geographic Area in 2021

4.5.8 HAL Recent Developments

4.6 Holister Stier

4.6.1 Holister Stier Corporation Information

4.6.2 Holister Stier Description, Business Overview

4.6.3 Holister Stier Allergy Immunotherapy Products Offered

4.6.4 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.6.5 Holister Stier Allergy Immunotherapy Sales by Product in 2021

4.6.6 Holister Stier Allergy Immunotherapy Sales by Application in 2021

4.6.7 Holister Stier Allergy Immunotherapy Sales by Geographic Area in 2021

4.6.8 Holister Stier Recent Development

4.7 Leti

4.7.1 Leti Corporation Information

4.7.2 Leti Description, Business Overview

4.7.3 Leti Allergy Immunotherapy Products Offered

4.7.4 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2017-2022)

4.7.5 Leti Allergy Immunotherapy Sales by Product in 2021

4.7.6 Leti Allergy Immunotherapy Sales by Application in 2021

4.7.7 Leti Allergy Immunotherapy Sales by Geographic Area in 2021

4.7.8 Leti Recent Development

5.1 Global Allergy Immunotherapy Sales by Type (2017-2028)

5.1.1 Global Allergy Immunotherapy Sales by Type (2017-2022)

5.1.2 Global Allergy Immunotherapy Sales Forecast by Type (2023-2028)

5.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2017-2028)

5.2 Global Allergy Immunotherapy Revenue Forecast by Type (2017-2028)

5.2.1 Global Allergy Immunotherapy Revenue by Type (2017-2022)

5.2.2 Global Allergy Immunotherapy Revenue Forecast by Type (2023-2028)

5.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2017-2028)

5.3 Allergy Immunotherapy Average Selling Price (ASP) by Type (2017-2028)

6.1 Global Allergy Immunotherapy Sales by Application (2017-2028)

6.1.1 Global Allergy Immunotherapy Sales by Application (2017-2022)

6.1.2 Global Allergy Immunotherapy Sales Forecast by Application (2023-2028)

6.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2017-2028)

6.2 Global Allergy Immunotherapy Revenue Forecast by Application (2017-2028)

6.2.1 Global Allergy Immunotherapy Revenue by Application (2017-2022)

6.2.2 Global Allergy Immunotherapy Revenue Forecast by Application (2023-2028)

6.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2017-2028)

6.3 Allergy Immunotherapy Average Selling Price (ASP) by Application (2017-2028)

7.1 North America Allergy Immunotherapy Market Size YoY Growth 2017-2028

7.2 North America Allergy Immunotherapy Market Facts & Figures by Country

7.2.1 North America Allergy Immunotherapy Sales by Country (2017-2028)

7.2.2 North America Allergy Immunotherapy Revenue by Country (2017-2028)

7.3 North America Allergy Immunotherapy Sales by Type

7.4 North America Allergy Immunotherapy Sales by Application

8.1 Asia-Pacific Allergy Immunotherapy Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Allergy Immunotherapy Market Facts & Figures by Region

8.2.1 Asia-Pacific Allergy Immunotherapy Sales by Region (2017-2028)

8.2.2 Asia-Pacific Allergy Immunotherapy Revenue by Region (2017-2028)

8.3 Asia-Pacific Allergy Immunotherapy Sales by Type

8.4 Asia-Pacific Allergy Immunotherapy Sales by Application

9.1 Europe Allergy Immunotherapy Market Size YoY Growth 2017-2028

9.2 Europe Allergy Immunotherapy Market Facts & Figures by Country

9.2.1 Europe Allergy Immunotherapy Sales by Country (2017-2028)

9.2.2 Europe Allergy Immunotherapy Revenue by Country (2017-2028)

9.3 Europe Allergy Immunotherapy Sales by Type

9.4 Europe Allergy Immunotherapy Sales by Application

10.1 Latin America Allergy Immunotherapy Market Size YoY Growth 2017-2028

10.2 Latin America Allergy Immunotherapy Market Facts & Figures by Country

10.2.1 Latin America Allergy Immunotherapy Sales by Country (2017-2028)

10.2.2 Latin America Allergy Immunotherapy Revenue by Country (2017-2028)

10.3 Latin America Allergy Immunotherapy Sales by Type

10.4 Latin America Allergy Immunotherapy Sales by Application

11.1 Middle East and Africa Allergy Immunotherapy Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country

11.2.1 Middle East and Africa Allergy Immunotherapy Sales by Country (2017-2028)

11.2.2 Middle East and Africa Allergy Immunotherapy Revenue by Country (2017-2028)

11.3 Middle East and Africa Allergy Immunotherapy Sales by Type

11.4 Middle East and Africa Allergy Immunotherapy Sales by Application

12.1 Allergy Immunotherapy Supply Chain Analysis

12.2 Allergy Immunotherapy Key Raw Materials and Upstream Suppliers

12.3 Allergy Immunotherapy Clients Analysis

12.4 Allergy Immunotherapy Sales Channel and Sales Model Analysis

12.4.1 Allergy Immunotherapy Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Allergy Immunotherapy Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Allergy Immunotherapy Distributors

13.1 Allergy Immunotherapy Industry Trends

13.2 Allergy Immunotherapy Market Drivers

13.3 Allergy Immunotherapy Market Challenges

13.4 Allergy Immunotherapy Market Restraints

13.5 Porter’s Five Forces Analysis

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Allergy Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Manufacturers of Subcutaneous Immunotherapy

    Table 3. Major Manufacturers of Sublingual Immunotherapy

    Table 4. Global Allergy Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2021 VS 2022 VS 2028

    Table 6. Global Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)

    Table 7. Global Allergy Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)

    Table 8. Global Allergy Immunotherapy Revenue by Region (2017-2022) & (US$ Million)

    Table 9. Global Allergy Immunotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 10. Global Allergy Immunotherapy Sales by Manufacturer (2017-2022) & (K Units)

    Table 11. Global Allergy Immunotherapy Sales Share by Manufacturer (2017-2022)

    Table 12. Allergy Immunotherapy Revenue by Manufacturer (2017-2022) & (US$ Million)

    Table 13. Allergy Immunotherapy Revenue Share by Manufacturer (2017-2022)

    Table 14. Key Manufacturers Allergy Immunotherapy Price (2017-2022) & (USD/Unit)

    Table 15. Ranking of Global Top Allergy Immunotherapy Manufacturers by Revenue (US$ Million) in 2021

    Table 16. Global Allergy Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 17. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2021)

    Table 18. Allergy Immunotherapy Manufacturers Manufacturing Base Distribution and Headquarters

    Table 19. Manufacturers Allergy Immunotherapy Product Type

    Table 20. Date of International Manufacturers Enter into Allergy Immunotherapy Market

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. ALK-Abello Corporation Information

    Table 23. ALK-Abello Description and Business Overview

    Table 24. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 25. ALK-Abello Allergy Immunotherapy Product

    Table 26. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 27. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 28. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 29. ALK-Abello Recent Development

    Table 30. Stallergenes Greer Corporation Information

    Table 31. Stallergenes Greer Description and Business Overview

    Table 32. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 33. Stallergenes Greer Allergy Immunotherapy Product

    Table 34. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 35. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 36. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 37. Stallergenes Greer Recent Development

    Table 38. Merck Corporation Information

    Table 39. Merck Description and Business Overview

    Table 40. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 41. Merck Allergy Immunotherapy Product

    Table 42. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 43. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 44. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 45. Merck Recent Development

    Table 46. Allergy Therapeutics Corporation Information

    Table 47. Allergy Therapeutics Description and Business Overview

    Table 48. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 49. Allergy Therapeutics Allergy Immunotherapy Product

    Table 50. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 51. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 52. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 53. Allergy Therapeutics Recent Development

    Table 54. HAL Corporation Information

    Table 55. HAL Description and Business Overview

    Table 56. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 57. HAL Allergy Immunotherapy Product

    Table 58. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 59. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 60. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 61. HAL Recent Development

    Table 62. Holister Stier Corporation Information

    Table 63. Holister Stier Description and Business Overview

    Table 64. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 65. Holister Stier Allergy Immunotherapy Product

    Table 66. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 67. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 68. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 69. Leti Corporation Information

    Table 70. Leti Description and Business Overview

    Table 71. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

    Table 72. Leti Allergy Immunotherapy Product

    Table 73. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021

    Table 74. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021

    Table 75. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021

    Table 76. Global Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 77. Global Allergy Immunotherapy Sales Forecast by Type (2023-2028) & (K Units)

    Table 78. Global Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

    Table 79. Global Allergy Immunotherapy Revenue Forecast by Type (2023-2028) & (US$ Million)

    Table 80. Global Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 81. Global Allergy Immunotherapy Sales Forecast by Application (2023-2028) & (K Units)

    Table 82. Global Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

    Table 83. Global Allergy Immunotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 84. North America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)

    Table 85. North America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)

    Table 86. North America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

    Table 87. North America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

    Table 88. North America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 89. North America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 90. Asia-Pacific Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)

    Table 91. Asia-Pacific Allergy Immunotherapy Sales by Region (2023-2028) & (K Units)

    Table 92. Asia-Pacific Allergy Immunotherapy Revenue by Region (2017-2028) & (US$ Million)

    Table 93. Asia-Pacific Allergy Immunotherapy Revenue by Region (2023-2028) & (US$ Million)

    Table 94. Asia-Pacific Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 95. Asia-Pacific Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 96. Europe Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)

    Table 97. Europe Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)

    Table 98. Europe Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

    Table 99. Europe Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

    Table 100. Europe Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 101. Europe Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 102. Latin America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)

    Table 103. Latin America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)

    Table 104. Latin America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

    Table 105. Latin America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

    Table 106. Latin America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 107. Latin America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 108. Middle East and Africa Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)

    Table 109. Middle East and Africa Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)

    Table 110. Middle East and Africa Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

    Table 111. Middle East and Africa Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

    Table 112. Middle East and Africa Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)

    Table 113. Middle East and Africa Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)

    Table 114. Allergy Immunotherapy Key Raw Materials, Industry Status and Trend

    Table 115. Allergy Immunotherapy Key Raw Materials and Upstream Suppliers

    Table 116. Allergy Immunotherapy Clients Status and Trend

    Table 117. Allergy Immunotherapy Typical Clients

    Table 118. Allergy Immunotherapy Distributors

    Table 119. Allergy Immunotherapy Market Trends

    Table 120. Allergy Immunotherapy Market Drivers

    Table 121. Allergy Immunotherapy Market Challenges

    Table 122. Allergy Immunotherapy Market Restraints

    Table 123. Research Programs/Design for This Report

    Table 124. Key Data Information from Secondary Sources

    Table 125. Key Data Information from Primary Sources

List of Figures

    Figure 1. Allergy Immunotherapy Product Picture

    Figure 2. Global Allergy Immunotherapy Sales Market Share by Type in 2021 & 2028

    Figure 3. Subcutaneous Immunotherapy Product Picture

    Figure 4. Sublingual Immunotherapy Product Picture

    Figure 5. Global Allergy Immunotherapy Sales Market Share by Application in 2021 & 2028

    Figure 6. Allergic Rhinitis Examples

    Figure 7. Allergic Asthma Examples

    Figure 8. Others Examples

    Figure 9. Allergy Immunotherapy Report Years Considered

    Figure 10. Global Allergy Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Allergy Immunotherapy Market Size 2017-2028 (US$ Million)

    Figure 12. Global Allergy Immunotherapy Sales 2017-2028 (K Units)

    Figure 13. Global Allergy Immunotherapy Market Size Market Share by Region: 2022 Versus 2028

    Figure 14. Global Allergy Immunotherapy Sales Market Share Forecast by Region (2017-2028)

    Figure 15. Global Allergy Immunotherapy Revenue Market Share by Region (2017-2028)

    Figure 16. Global Allergy Immunotherapy Sales Share by Manufacturer in 2021

    Figure 17. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 18. Global Allergy Immunotherapy Sales Market Share Forecast by Type (2017-2028)

    Figure 19. Global Allergy Immunotherapy Revenue Market Share Forecast by Type (2017-2028)

    Figure 20. Allergy Immunotherapy Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)

    Figure 21. Global Allergy Immunotherapy Sales Market Share Forecast by Application (2017-2028)

    Figure 22. Global Allergy Immunotherapy Revenue Market Share Forecast by Application (2017-2028)

    Figure 23. Allergy Immunotherapy Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)

    Figure 24. North America Allergy Immunotherapy Revenue 2017-2028 (US$ Million)

    Figure 25. North America Allergy Immunotherapy Sales Market Share by Type (2017-2022)

    Figure 26. North America Allergy Immunotherapy Sales Market Share by Application (2017-2022)

    Figure 27. Asia-Pacific Allergy Immunotherapy Revenue 2017-2028 (US$ Million)

    Figure 28. Asia-Pacific Allergy Immunotherapy Sales Market Share by Region (2017-2028)

    Figure 29. Asia-Pacific Allergy Immunotherapy Revenue Market Share by Region (2017-2028)

    Figure 30. Asia-Pacific Allergy Immunotherapy Sales Market Share by Type (2017-2022)

    Figure 31. Asia-Pacific Allergy Immunotherapy Sales Market Share by Application (2017-2022)

    Figure 32. Europe Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 33. Europe Allergy Immunotherapy Sales Market Share by Country (2017-2028)

    Figure 34. Europe Allergy Immunotherapy Revenue Market Share by Country (2017-2028)

    Figure 35. Europe Allergy Immunotherapy Sales Market Share by Type (2017-2022)

    Figure 36. Europe Allergy Immunotherapy Sales Market Share by Application (2017-2022)

    Figure 37. Latin America Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 38. Latin America Allergy Immunotherapy Sales Market Share by Country (2017-2028)

    Figure 39. Latin America Allergy Immunotherapy Revenue Market Share by Country (2017-2022)

    Figure 40. Latin America Allergy Immunotherapy Sales Market Share by Type (2017-2022)

    Figure 41. Latin America Allergy Immunotherapy Sales Market Share by Application (2017-2022)

    Figure 42. Middle East and Africa Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 43. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2017-2028)

    Figure 44. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Country (2017-2028)

    Figure 45. Middle East and Africa Allergy Immunotherapy Sales Market Share by Type (2017-2022)

    Figure 46. Middle East and Africa Allergy Immunotherapy Sales Market Share by Application (2017-2022)

    Figure 47. Allergy Immunotherapy Supply Chain (Upstream and Downstream Market)

    Figure 48. Global Production Market Share of Allergy Immunotherapy Raw Materials by Region in 2021

    Figure 49. Allergy Immunotherapy Distribution Channels

    Figure 50. Global Allergy Immunotherapy Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 51. Global Allergy Immunotherapy Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation